Nanoparticles for neuroimaging

Journal of Physics D: Applied Physics

Volumn 45, Issue 7, 2012, Pages

  Re, F ^a   Moresco, R ^b   Masserini, M ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD-BRAIN BARRIER; BRAIN DISORDERS; CENTRAL NERVOUS SYSTEMS; CURRENT STATUS; DIAGNOSTIC TOOLS; FUNCTIONALIZATIONS; IN-VIVO; NEURO-IMAGING; TARGET ORGANS; ULTRA-SMALL;

ENDOTHELIAL CELLS; IMAGING TECHNIQUES; MEDICAL NANOTECHNOLOGY; MOLECULAR IMAGING; TISSUE;

NANOPARTICLES;

EID: 84857279476     PISSN: 00223727     EISSN: 13616463     Source Type: Journal    
DOI: 10.1088/0022-3727/45/7/073001     Document Type: Review

References (110)

1. Abbott N J, Patabendige A A, Dolman D E, Yusof S R and Begley D 2010 Structure and function of the blood-brain barrier J. Neurobiol. Dis. 37 1325
2. Appel S H, Zhao W, Beers D R and Henkel J S 2011 The microglial- motoneuron dialogue in ALS Acta Myol. 30 48
3. Baeten K, Hendriks J J, Hellings N, Theunissen E, Vanderlocht J, Ryck L D, Gelan J, Stinissen P and Adriaensens P J 2008 Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging Neuroimmunol. 195 16
4. Barbu E, Molǹr E, Tsibouklis J and Grecki D C 2009 The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier Expert Opin. Drug Deliv. 6 55365
5. Batavelji D, Stamenkovi S, Bai G and Andjus P R 2011 Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis Acta Physiol. Hung. 98 2731
6. Beaumont M, Lemasson B, Farion R, Segebarth C, Ŕmy C and Barbier E L 2009 Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI J. Cereb. Blood Flow Metab. 29 171426
7. Beckmann N, Ǵrard C, Abramowski D, Cannet C and Staufenbiel M 2011 Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy J. Neurosci. 31 102331
8. Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente J M, Graz V, Borm P, Estrada G, Ntziachristos V and Razansky D 2010 Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging Part. Fibre Toxicol. 7 3
9. Boado R J 2008 A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery Drug News Perspect. 21 489503
10. Bradley W G Jr 1986 Magnetic resonance imaging in the central nervous system: comparison with computed tomography Magn. Reson. Annu. 81-122
11. Brochet B, Deloire M S, Touil T, Anne O, Cailĺ J M, Dousset V and Petry K G 2006 Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE Neuroimage 32 26674
12. Buse J and El-Aneed A 2010 Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances Nanomedicine (Lond.) 5 123760
13. Calvo P, Gouritin B, Villarroya H, Eclancher F, Giannavola C, Klein C, Andreux J P and Couvreur P 2002 Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat Eur. J. Neurosci. 15 131726 (Pubitemid 35477993)
14. Canovi M et al 2011 The binding affinity of anti-A1-42 MAb-decorated nanoliposomes to A1-42 peptides in vitro and to amyloid deposits in post-mortem tissue Biomaterials 32 548997
15. Carlos T M et al 1990 Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells Blood 76 96570 (Pubitemid 20295509)
16. Chapon C, Franconi F, Lacoeuille F, Hindŕ F, Saulnier P, Benoit J P, Le Jeune J J and Lemaire L 2009 Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent MAGMA 22 16774
17. Chertok B, Moffat B A, David A E, Yu F, Bergemann C, Ross B D and Yang V C 2008 Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors Biomaterials 29 48796 (Pubitemid 350100794)
18. Chou S W, Shau Y H, Wu P C, Yang Y S, Shieh D B and Chen C C 2010 In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging J. Am. Chem. Soc. 132 132708
19. Christoforidis G A et al 2009 High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide Invest. Radiol. 44 37583
20. Claes A, Gambarota G, Hamans B, van Tellingen O, Wesseling P, Maass C, Heerschap A and Leenders W 2008 Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment Int. J. Cancer 122 19816 (Pubitemid 351441186)
21. Correale J and Villa A 2009 Cellular elements of the blood-brain barrier Neurochem. Res. 34 206777
22. de Vries E F, Dierckx R A and Klein H C 2006 Nuclear imaging of inflammation in neurologic and psychiatric disorders Curr. Clin. Pharmacol. 1 22942
23. Dousset V, Ballarino L, Delalande C, Coussemacq M, Canioni P, Petry K G and Cailĺ J M 1999a Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis AJNR Am. J. Neuroradiol. 20 2237 (Pubitemid 30418702)
24. Dousset V, Delalande C, Ballarino L, Quesson B, Seilhan D, Coussemacq M, Thiaudíre E, Brochet B, Canioni P and Cailĺ J M 1999b In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance Magn. Reson. Med. 41 32933 (Pubitemid 29104519)
25. Dousset V, Gomez C, Petry K G, Delalande C and Caille J M 1999c Dose and scanning delay using USPIO for central nervous system macrophage imaging MAGMA 8 1859 (Pubitemid 29436571)
26. Dousset V, Brochet B, Deloire M S, Lagoarde L, Barroso B, Caille J M and Petry K G 2006 MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium AJNR Am. J. Neuroradiol. 27 10005 (Pubitemid 44897675)
27. Elices M J, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler M E and Lobb R R 1990 VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site Cell 60 57784
28. Fillmore H L et al 2011 Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors Nanomedicine (Lond.) 6 44958
29. Floris S, Blezer E L, Schreibelt G, Dopp E, van der Pol S M, Schadee-Eestermans I L, Nicolay K, Dijkstra C D and de Vries H E 2004 Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study Brain 127 61627 (Pubitemid 38295477)
30. Gabathuler R 2010 Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiol. Dis. 37 4857
31. Ghaghada K B, Colen R R, Hawley C R, Patel N and Mukundan S Jr 2010 Liposomal contrast agents in brain tumor imaging Neuroimaging Clin. N. Am. 20 36778
32. Gobbi M et al 2010 Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide Biomaterials 31 651929
33. Greish K 2007 Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines J. Drug Target 15 45764 (Pubitemid 47209047)
34. Hahn M A, Singh A K, Sharma P, Brown S C and Moudgil B M 2011 Nanoparticles as contrast agents for in vivo bioimaging: current status and future perspectives Anal. Bioanal. Chem. 399 327
35. Hainfeld J F, Slatkin D N, Focella T M and Smilowitz H M 2006 Gold nanoparticles: a new x-ray contrast agent Br. J. Radiol. 79 24853
36. Hasan M K and Mooney R P 2011 The predisposing factors, biological markers, neuroimaging techniques and medical complications associated with Alzheimer's disease W. V. Med. J. 107 269
37. Herholz K and Ebmeier K 2011 Clinical amyloid imaging in Alzheimer's disease Lancet Neurol. 10 66770
38. Hutter E, Boridy S, Labrecque S, Lalancette-H́bert M, Kriz J, Winnik F M and Maysinger D 2010 Microglial response to gold nanoparticles ACS Nano 4 2595606
39. Jander S, Schroeter M and Saleh A 2007 Imaging inflammation in acute brain ischemia Stroke 38 6425 (Pubitemid 46184233)
40. Jin A Y, Tuor U I, Rushforth D, Filfil R, Kaur J, Ni F, Tomanek B and Barber P A 2009 Magnetic resonance molecular imaging of post-stroke neuroinflammation with a P-selectin targeted iron oxide nanoparticle Contrast Media Mol. Imaging 4 30511
41. Khairallah M I and Kassem L A 2011 Alzheimer's disease: current status of etiopathogenesis and therapeutic strategies Pak. J. Biol. Sci. 14 25772
42. Kim J, Kim D I, Lee S K, Kim D J, Lee J E and Ahn S K 2008 Imaging of the inflammatory response in reperfusion injury after transient cerebral ischemia in rats: correlation of superparamagnetic iron oxide-enhanced magnetic resonance imaging with histopathology Acta Radiol. 49 5808
43. Kleinschnitz C, Schtz A, Nlte I, Horn T, Frank M, Solymosi L, Stoll G and Bendszus M 2005 In vivo detection of developing vessel occlusion in photothrombotic ischemic brain lesions in the rat by iron particle enhanced MRI J. Cereb. Blood Flow Metab. 25 154855 (Pubitemid 41541963)
44. Krauze M T, Forsayeth J, Yin D and Bankiewicz K S 2009 Convection-enhanced delivery of liposomes to primate brain Methods Enzymol. 465 34962
45. Kulkarni P V, Roney C A, Antich P P, Bonte F J, Raghu A V and Aminabhavi T M 2010 Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2 3547
46. Lacroix L M, Ho D and Sun S 2010 Magnetic nanoparticles as both imaging probes and therapeutic agents Curr. Top. Med. Chem. 10 118497
47. Liu C H, You Z, Ren J, Kim Y R, Eikermann-Haerter K and Liu P K 2008 Noninvasive delivery of gene targeting probes to live brains for transcription MRI FASEB J. 22 1193203 (Pubitemid 351519973)
48. Liu S, Han Y, Yin L, Long L and Liu R 2008 Toxicology studies of a superparamagnetic iron oxide nanoparticle in vivo Adv. Mater. Res. 4750 1097100
49. Lbbe A S et al 1996 Clinical experiences with magnetic drug targeting: a phase I study with 4-epidoxorubicin in 14 patients with advanced solid tumors Cancer Res. 56 468693
50. Machtoub L, Batavelji D and Andjus P R 2011 Molecular imaging of brain lipid environment of lymphocytes in amyotrophic lateral sclerosis using magnetic resonance imaging and SECARS microscopy Physiol. Res. 60 Suppl. 1: S1217
51. Manninger S P, Muldoon L L, Nesbit G, Murillo T, Jacobs P M and Neuwelt E A 2005 An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions AJNR Am. J. Neuroradiol. 26 2290300
52. Mao C Q, Du J Z, Sun T M, Yao Y D, Zhang P Z, Song E W and Wang J 2011 A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy Biomaterials 32 312433
53. Markoutsa E, Pampalakis G, Niarakis A, Romero I A, Weksler B, Couraud P O and Antimisiaris S G 2011 Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line Eur. J. Pharm. Biopharm. 77 26574
54. McAteer M A and Choudhury R P 2009 Applications of nanotechnology in molecular imaging of the brain Prog. Brain Res. 180 7296
55. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny E J and Daldrup-Link H E 2004 Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro Eur. Radiol. 14 18518 (Pubitemid 39386634)
56. Mohs A M and Provenzale J M 2010 Applications of nanotechnology to imaging and therapy of brain tumors Neuroimaging Clin. N. Am. 20 28392
57. Montet X, Montet-Abou K, Reynolds F, Weissleder R and Josephson L 2006 Nanoparticle imaging of integrins on tumor cells Neoplasia 8 21422 (Pubitemid 43671237)
58. Muldoon L L, S̀ndor M, Pinkston K E and Neuwelt E A 2005 Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor Neurosurgery 57 78596
59. Murillo T P, Sandquist C, Jacobs P M, Nesbit G, Manninger S and Neuwelt E A 2005 Imaging brain tumors with ferumoxtran-10, a nanoparticle magnetic resonance contrast agent Therapy 2 87183
60. Murphy C J, Gole A M, Stone J W, Sisco P N, Alkilany A M, Goldsmith E C and Baxter S C 2008 Gold nanoparticles in biology: beyond toxicity to cellular imaging Acc. Chem. Res. 41 172130
61. Naganska E and Matyja E 2011 Amyotrophic lateral sclerosislooking for pathogenesis and effective therapy Folia Neuropathol. 49 113
62. Neuwelt E A, Vrallyay P, Bag A G, Muldoon L L, Nesbit G and Nixon R 2004 Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours Neuropathol. Appl. Neurobiol. 30 45671 (Pubitemid 39423033)
63. Nighoghossian N et al 2007 Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients Stroke 38 3037 (Pubitemid 46184299)
64. Ocampo-Garca B, Ferro-Flores G, Morales-Avila E and Ramrez Fde M 2011 Kit for preparation of multimeric receptor-specific 99mTc-radiopharmaceuticals based on gold nanoparticles Nucl. Med. Commun. 32 1095104
65. Oku N, Yamashita M, Katayama Y, Urakami T, Hatanaka K, Shimizu K, Asai T, Tsukada H, Akai S and Kanazawa H 2011 PET imaging of brain cancer with positron emitter-labeled liposomes Int. J. Pharm. 403 1707
66. Olivier JC, Fenart L, Chauvet R, Pariat C, Cecchelli R and Couet W 1999 Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity Pharm. Res. 16 183642 (Pubitemid 30040699)
67. Oude Engberink R D, Blezer E L, Dijkstra C D, van der Pol S M, van der Toorn A and de Vries H E 2010 Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis NMR Biomed. 23 108796
68. Oude Engberink R D, Blezer E L, Hoff E I, van der Pol S M, van der Toorn A, Dijkhuizen R M and de Vries H E 2008 MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO J. Cereb. Blood Flow Metab. 28 84151 (Pubitemid 351432793)
69. Petkar K C, Chavhan S S, Agatonovik-Kustrin S and Sawant K K 2011 Nanostructured materials in drug and gene delivery: a review of the state of the art Crit. Rev. Ther. Drug Carrier Syst. 28 10164
70. Plotkin M, Gneveckow U, Meier-Hauff K, Amthauer H, Feussner A, Denecke T, Gutberlet M, Jordan A, Felix R and Wust P 2006 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma Int. J. Hyperthermia 22 31925 (Pubitemid 43878854)
71. Poduslo J F, Hultman K L, Curran G L, Preboske G M, Chamberlain R, Marjaska M, Garwood M, Jack C R Jr and Wengenack T M 2011 Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid protein antibody-coated nanoparticles J. Neuropathol. Exp. Neurol. 70 65361
72. Price C J, Warburton E A and Menon D K 2003 Human cellular inflammation in the pathology of acute cerebral ischaemia J. Neurol. Neurosurg. Psychiatry 74 147684
73. Provenzale J M and Silva G A 2006 Uses of nanoparticles for central nervous system imaging and therapy AJNR Am. J. Neuroradiol. 30 1293301
74. Rausch M, Baumann D, Neubacher U and Rudin M 2002 In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO NMR Biomed. 15 27883 (Pubitemid 34716324)
75. Rausch M, Hiestand P, Baumann D, Cannet C and Rudin M 2003 MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE Magn. Reson. Med. 50 30914 (Pubitemid 36950850)
76. Rausch M, Hiestand P, Foster C A, Baumann D R, Cannet C and Rudin M 2004 Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging J. Magn. Reson. Imaging 20 1624 (Pubitemid 38857512)
77. Rausch M, Sauter A, Frhlich J, Neubacher U, Rad E W and Rudin M 2001 Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage Magn. Reson. Med. 46 101822 (Pubitemid 33019928)
78. Re F et al 2011a Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model Nanomedicine 7 5519
79. Re F, Cambianica I, Sesana S, Salvati E, Cagnotto A, Salmona M, Couraud P O, Moghimi S M, Masserini M and Sancini G 2011b Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide J. Biotechnol. 156 3416
80. Rivet C J, Yuan Y, Borca-Tasciuc D A and Gilbert R J 2011 Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity Chem. Res. Toxicol.
81. Runge V M and Gelblum D Y 1991 Future directions in magnetic resonance contrast media Top Magn. Reson Imaging 3 8597
82. Saleh A, Schroeter M, Jonkmanns C, Hartung H P, Mdder U and Jander S 2004 In vivo MRI of brain inflammation in human ischaemic stroke Brain 127 16707 (Pubitemid 38899419)
83. Saleh A, Schroeter M, Ringelstein A, Hartung H P, Siebler M, Mdder U and Jander S 2007 Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke Stroke 38 27337 (Pubitemid 47494011)
84. Sarin H et al 2008 Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells J. Transl. Med. 6 80
85. Sarin H, Kanevsky A S, Wu H, Sousa A A, Wilson C M, Aronova M A, Griffiths G L, Leapman R D and Vo H Q 2009 Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors J. Transl. Med. 7 51
86. Schroeter M, Saleh A, Wiedermann D, Hoehn M and Jander S 2004 Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia Magn. Reson. Med. 52 4036 (Pubitemid 39025286)
87. Sekeljic V, Bataveljic D, Stamenkovic S, Uamek M, Jaboski M, Radenovic L, Pluta R and Andjus P R 2011 Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model Brain Struct. Funct. doi:10.1007/s00429-011-0336-7
88. Shin J, Anisur R M, Ko M K, In G H, Lee J H and Lee I S 2009 Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery Angew. Chem. Int. Ed. Engl. 48 3214
89. Slomka P J and Baum R P 2009 Multimodality image registration with software: state-of-the-art Eur. J. Nucl. Med. Mol. Imaging 36 S4455
90. Sosnovik D E, Nahrendorf M and Weissleder R 2008 Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications Basic Res. Cardiol. 103 12230 (Pubitemid 351356755)
91. Sousa F et al 2010 Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study Nanoscale 2 282634
92. Stoll G, Jander S and Schroeter M 1998 Inflammation and glial responses in ischemic brain lesions Prog. Neurobiol. 56 14971 (Pubitemid 28432563)
93. Streit W J 2006 Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci. 29 50610 (Pubitemid 44291814)
94. Stroh A et al 2006 Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging Neuroimage 33 88697 (Pubitemid 44739995)
95. Sun C, Veiseh O, Gunn J, Fang C, Hansen S, Lee D, Sze R, Ellenbogen R G, Olson J and Zhang M 2008 In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes Small 4 3729 (Pubitemid 351421268)
96. Swerdlow R H 2007 PET sheds light on Alzheimer's disease genetic risk Proc. Natl Acad. Sci. USA 104 188812
97. Taheri S, Gasparovic C, Shah N J and Rosenberg G A 2011 Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping Magn. Reson. Med. 65 103642
98. Tysiak E, Asbach P, Aktas O, Waiczies H, Smyth M, Schnorr J, Taupitz M and Wuerfel J 2009 Beyond blood-brain barrier breakdownin vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI J. Neuroinflammation 6 20
99. van Rooy I, Mastrobattista E, Storm G, Hennink W E and Schiffelers R M 2011 Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain J. Control. Release 150 306
100. Veiseh O et al 2009 Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier Cancer Res. 69 62007
101. Winer J L, Kim P E, Law M, Liu C Y and Apuzzo M L 2011 Visualizing the future: enhancing neuroimaging with nanotechnology World Neurosurg. 75 62637
102. Win-Shwe T T and Fujimaki H 2011 Nanoparticles and neurotoxicity Int. J. Mol. Sci. 12 626780
103. Wong D F and Kuhar M J 1988 In vivo PET and SPECT receptor imaging: new technology and tactics for receptor measurement Adv. Exp. Med. Biol. 236 18193
104. Wood P L 2003 Roles of microglia in chronic neurodegenerative diseases Neuroinflammation: Mechanisms and Management 2nd edn ed P L Wood (New Jersey: Humana Press) pp 327
105. Wrensch M, Minn Y, Chew T, Bondy M and Berger M S 2002 Epidemiology of primary brain tumors: current concepts and review of the literature Neuro. Oncol. 4 27899
106. Wu X et al 2008 In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation J. Neurosurg. 108 3209 (Pubitemid 351213297)
107. Xie H, Zhu Y, Jiang W, Zhou Q, Yang H, Gu N, Zhang Y, Xu H, Xu H and Yang X 2011 Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo Biomaterials 32 495502
108. Yang J, Wadghiri Y Z, Hoang D M, Tsui W, Sun Y, Chung E, Li Y, Wang A, de Leon M and Wisniewski T 2011 Detection of amyloid plaques targeted by USPIO-A1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging Neuroimage 55 16009
109. Youns M, Hoheisel J D and Efferth T 2011 Therapeutic and diagnostic applications of nanoparticles Curr. Drug Targets 12 35765
110. Zimmer C, Weissleder R, Poss K, Bogdanova A, Wright S C Jr and Enochs W S 1995 MR imaging of phagocytosis in experimental gliomas Radiology 197 5338